Author

C. Klemm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Organism:yeast· 1

Frequent Co-Authors

C. Busonero· 1 shared F. Acconcia· 1 shared G. Olafsson· 1 shared P. H. Thorpe· 1 shared S. Leone· 1 shared

Activity by Year

2017-2023 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 4 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Busonero

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Synthetic cell-cycle regulation identifies Mif2CENP-C as a CDK phospho-target at the kinetochore.

C. Klemm, G. Olafsson, P. H. Thorpe

The paper identifies Mif2CENP-C as a CDK phospho-target at the kinetochore by using a synthetic CDK complex to study cell-cycle regulation in yeast.

bioRxiv · Mar 24, 2023 · PreprintCell Biology

A Functional Drug Re-Purposing Screening Identifies Carfilzomib As A Drug Preventing 17β-Estradiol: ERα Signaling And Cell Proliferation In Breast Cancer Cells

C. Busonero, S. Leone, C. Klemm, F. Acconcia

This study identifies carfilzomib as a drug that prevents 17β-estradiol:ERα signaling and inhibits cell proliferation in breast cancer cells, showing efficacy in tamoxifen-resistant models.

bioRxiv · May 3, 2017Cancer Biology